News | July 15, 2025
Capricor receives FDA’s CRL for Deramiocel BLA for duchenne muscular dystrophy
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
These medicines are essential in preventing RhD immunisation during pregnancy
Star Health Insurance is modernising its claims ecosystem to be future-ready
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Sun Pharma discontinues work on its experimental skin drug SCD-044 after Phase 2 trial results fall short of goals for treating psoriasis and atopic dermatitis
Vepdegestrant is the first and only PROteolysis TArgeting Chimera (PROTAC) evaluated in a Phase 3 clinical trial and the first to show benefit in patients with breast cancer
She has held senior positions at Coca-Cola in China and PepsiCo in India
Scores highest PAT of Rs. 118 crore in FY25
Topiramate is indicated as a treatment of epilepsy and migraine
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Subscribe To Our Newsletter & Stay Updated
